Transplantation Proceedings
Volume 33, Issue 3, Supplement 1 , Pages S7-S10 , May 2001

Tailoring therapy: balancing toxicity and chronic allograft dysfunction

  • P.F Halloran

      Affiliations

    • Department of Medicine, Division of Nephrology & Immunology, University of Alberta, Edmonton, Alberta, Canada
    • Corresponding Author InformationAddress reprint requests to Dr Philip F. Halloran, Director, Division of Nephrology & Immunology, University of Alberta, 250 Heritage Medical Research Centre, Edmonton, Alberta T6G 2S2, Canada
    • ,
  • A Melk

      Affiliations

    • Department of Medicine, Division of Nephrology & Immunology, University of Alberta, Edmonton, Alberta, Canada

References 

  1. Hume DM, Merrill JP, Miller BF, et al.  J Clin Invest. 1955;34:327
  2. Jeannet M, Pinn VW, Flax MH, et al.  N Engl J Med. 1970;282:111
  3. Hariharan S, Johnson CP, Bresnahan BA, et al.  N Engl J Med. 2000;342:605
  4. Cicciarelli J, Iwaki Y, Mendenz R. In:  Cecka JM,  Terasaki PI editor. Clinical Transplants 1999. Los Angeles, Calif: UCLA Tissue Typing Laboratory; 2000;p. 335
  5. Trpkov K, Campbell P, Pazderka F, et al.  Transplantation. 1996;61:1586
  6. Collins AB, Schneeberger EE, Pascual MA, et al.  J Am Soc Nephrol. 1999;10:2208
  7. Myers BD, Ross J, Newton L, et al.  N Engl J Med. 1984;311:699
  8. Sharon E, Kaplan D, Diamond HS. New Engl J Med. 1973;288:122
  9. Hall BM, Tiller DJ, Hardie I, et al.  N Engl J Med. 1988;318:1499

PII: S0041-1345(01)02054-1

Transplantation Proceedings
Volume 33, Issue 3, Supplement 1 , Pages S7-S10 , May 2001

Article Tools

* Image Usage & Resolution